about
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the pote...
Read More
4.38
0.13
(3.06%)
1.4M
XNAS Volume
High vol.+gain this week
XNAS 18 Dec, 2025 4:16 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Climb Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..